2019
DOI: 10.31688/abmu.2019.54.3.10
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of bone mineral density and densitometry data in patients with osteoarthritis, non-alcoholic steatohepatitis and obesity

Abstract: Caractéristiques des données de densité et de densitométrie minérale osseuse chez des patients atteints d'ostéoarthrite, combinées d'une stéatose hépatique non-alcoolique et d' obésité L'objectif de l'étude était de déterminer les caractéristiques de la densité minérale osseuse chez les patients souffrant d'arthrose, associées à une stéatose hépatique non-alcoolique et à l'obésité. Matériel et méthodes. 90 patients ont été examinés et répartis en trois groupes: 1 groupe (n = 30) était composé de patients souff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Femoral neck aBMD by DXA . Femoral neck aBMD by DXA was reported in 48 studies [ 52 , 54 , 56 , 58 60 , 67 72 , 84 , 85 , 88 , 89 , 92 , 93 , 96 , 97 , 101 , 103 , 106 108 , 110 – 114 , 118 , 120 , 121 , 124 , 128 , 130 , 142 , 144 , 148 153 , 167 , 173 , 177 , 180 , 181 ], including 30,577 participants. Obesity was associated with increased femoral neck aBMD in postmenopausal women (n = 21: MD = 0.06 g/cm 2 , 95% CI: 0.05, 0.08, P<0.00001, I 2 = 90%), premenopausal women (n = 13: MD = 0.05 g/cm 2 , 95% CI: 0.03, 0.07, P<0.00001, I 2 = 92%), men (n = 8: MD = 0.05 g/cm 2 , 95% CI: 0.03, 0.07, P<0.00001, I 2 = 79%), and in studies combining men and women (n = 7: MD = 0.07 g/cm 2 , 95% CI: 0.04, 0.10, P<0.00001, I 2 = 77%) ( S2 Fig ).…”
Section: Resultsmentioning
confidence: 99%
“…Femoral neck aBMD by DXA . Femoral neck aBMD by DXA was reported in 48 studies [ 52 , 54 , 56 , 58 60 , 67 72 , 84 , 85 , 88 , 89 , 92 , 93 , 96 , 97 , 101 , 103 , 106 108 , 110 – 114 , 118 , 120 , 121 , 124 , 128 , 130 , 142 , 144 , 148 153 , 167 , 173 , 177 , 180 , 181 ], including 30,577 participants. Obesity was associated with increased femoral neck aBMD in postmenopausal women (n = 21: MD = 0.06 g/cm 2 , 95% CI: 0.05, 0.08, P<0.00001, I 2 = 90%), premenopausal women (n = 13: MD = 0.05 g/cm 2 , 95% CI: 0.03, 0.07, P<0.00001, I 2 = 92%), men (n = 8: MD = 0.05 g/cm 2 , 95% CI: 0.03, 0.07, P<0.00001, I 2 = 79%), and in studies combining men and women (n = 7: MD = 0.07 g/cm 2 , 95% CI: 0.04, 0.10, P<0.00001, I 2 = 77%) ( S2 Fig ).…”
Section: Resultsmentioning
confidence: 99%
“…Studies that have looked at the effects on insulin resistance following vitamin D administration in obese people are contradictor y. Vitamin D deficiency is associated with hyperglycemia, hyperinsulinemia and insulin resistance [41,42]. Von Hurst et al, following vitamin D treatment in women with insulin resistance and overweight, showed a decrease in HOMA-IR, but with no effect on glucose level, lipid profile and inflammatory markers [40].…”
Section: Vitamin D Supplementationmentioning
confidence: 99%